Glycidyl stearate 硬脂酸缩水甘油基酯
CAS 7460-84-6 MFCD00059110
化学结构图
SMILES: CCCCCCCCCCCCCCCCCC(=O)OCC1CO1
化学属性
| Mol. Formula | C21H40O3 |
|---|---|
| Mol. Weight | 340.55 |
| Boiling Point | 193 °C at 1 mmHg |
| Melting Point | 53 °C |
别名和识别编码
| Chemical Name | Glycidyl Stearate |
|---|---|
| CAS Number | 7460-84-6 |
| Synonym | Glycidyl stearate {LY} Glycidyl stearate glycidyl stearate oxiranylmethyl octadecanoate {} {LY} Glycidyl stearate {} {} {LY} Glycidyl stearate {} {} {} {LY} Glycidyl stearate {} {} {} {} {LY} Glycidyl stearate {} {} {} {} {} {LY} Glycidyl stearate {} {} {} {} {} {} {LY} Glycidyl stearate {} {} {} {} {} {} {} {LY} Glycidyl stearate {} {} {} {} {} {} {} {} {LY} Glycidyl stearate {} {} {} {} {} {} {} {} {} {LY} Glycidyl stearate {} {} {} {} {} {} {} {} {} {} {LY} Glycidyl stearate {} {} {} {} {} {} {} {} {} {} {} {LY} Glycidyl stearate {} {} {} {} {} {} {} {} {} {} {} {} {LY} Glycidyl stearate {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Glycidyl stearate {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Glycidyl stearate {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Glycidyl stearate {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} { {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Glycidyl st |
| MDL Number | MFCD00059110 |
| Reaxys-RN | 224859 |
| PubChem Substance ID | 62642 |
| Chemical Name Translation | 硬脂酸缩水甘油基酯 |
| InChIKey | OUQGOXCIUOCDNN-UHFFFAOYSA-N |
| Wiswesser Line Notation | T3OTJ B1OV18 |
| Beilstein Registry Number | 0224859 |
| LabNetwork Molecule ID | LN01291600 |
| InChI | InChI=1S/C21H40O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(22)24-19-20-18-23-20/h20H,2-19H2,1H3 |
| Canonical SMILES | CCCCCCCCCCCCCCCCCC(OCC1CO1)=O |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- Glycerols
- Fatty Acid Derivatives & Lipids
- Heterocycles
产品应用
- Acid-hydrolyzable ester derivatives as low calorie fat mimetics
相关文献及参考
- Swern, D., et al.: Cancer Res., 30, 1037 (1970),
安全信息
TYPE OF TEST : TD - Toxic dose (other than lowest) ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 52 mg/kg/26W-I TOXIC EFFECTS : Tumorigenic - equivocal tumorigenic agent by RTECS criteria Tumorigenic - tumors at site of application REFERENCE : CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year: 32,880,1972
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 2500 mg/kg/5W-I TOXIC EFFECTS : Tumorigenic - equivocal tumorigenic agent by RTECS criteria Tumorigenic - facilitates action of known carcinogen REFERENCE : ANYAA9 Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- Volume(issue)/page/year: 68,750,1958
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 52 mg/kg/26W-I TOXIC EFFECTS : Tumorigenic - equivocal tumorigenic agent by RTECS criteria Lungs, Thorax, or Respiration - tumors Tumorigenic - tumors at site of application REFERENCE : CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year: 30,1037,1970
TYPE OF TEST : Cytogenetic analysis ROUTE OF EXPOSURE : Intraperitoneal TEST SYSTEM : Rodent - rat DOSE/DURATION : 500 mg/kg REFERENCE : BJPCAL British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. Volume(issue)/page/year: 6,235,1951
京ICP备2020036287号